Hormone replacement therapy (estrogen/progesterone)
Contents
Description
Hormone replacement therapy with estrogen and progesterone is used to manage symptoms of premature ovarian failure and prevent long-term complications. It helps maintain bone density, cardiovascular health, and quality of life in women with early ovarian insufficiency. Treatment is typically continued until the natural age of menopause.
Indications & Therapeutic Use
premature ovarian failure, primary ovarian insufficiency, menopausal symptoms, osteoporosis prevention
Linked Diseases:
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Hormone replacement therapy (estrogen/progesterone) — GNH India
11 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | hormone replacement therapy (estrogen/progesterone) |
| Brands | 1 brand available |
| Active Ingredient | conjugated estrogens |
| Drug Class | premature ovarian failure |
| Manufacturer | Pfizer |
| Dosage Forms | oral tablet 0.3mg, 0.45mg, 0.625mg, 0.9mg, 1.25mg; transdermal patch; vaginal cream |
| Medical Code | G03CA57 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Countries | 8 countries |